Brain Diseases - Chemically induced
Research News and Information

Monday, November 23, 2009

Parathyroid surgery and methylene blue: a review with guidelines for safe intraoperative use.

29 Sep 2009 Methylene blue has been used to help facilitate parathyroid surgery for over 30 years. Its use has been widely considered both safe and cost effective. Twenty-six cases of a toxic metabolic encephalopathy, however, have been reported with its use. ... Read more...

Adverse effects of anticancer agents that target the VEGF pathway.

5 Jul 2009 Antiangiogenesis agents that target the VEGF/VEGF receptor pathway have become an important part of standard therapy in multiple cancer indications. With expanded clinical experience with this class of agents has come the increasing recognition of ... Read more...

[Importance of selective A1 agonists for the protection of brain and heart against injuring factors]

29 Jun 2009 Powerful selective A1 agonist N6-cyclopentyladenosine (CPA) effectively protects the brain (upon decapitation) and the heart (upon intoxication by KCl or ethylen glycol tetra acetate (EGTA)) against the action of injuring factors on experimental ... Read more...

Latest indexed articles for 'Brain Diseases - Chemically induced'

These are the very latest articles for this heading:

• Parathyroid surgery and methylene blue: a review with guidelines for safe intraoperative use. 29 Sep 2009
• Adverse effects of anticancer agents that target the VEGF pathway. 5 Jul 2009
• [Importance of selective A1 agonists for the protection of brain and heart against injuring factors] 29 Jun 2009
• Heroin vapor inhalation-induced spongiform leukoencephalopathy. 30 May 2009
• The utility of early brain imaging (diffusion magnetic resonance and single photon emission computed tomography scan) in assessing the course of acute sodium monofluoroacetate intoxication. 30 May 2009
• Gene expression studies reveal that DNA damage, vascular perturbation, and inflammation contribute to the pathogenesis of carbonyl sulfide neurotoxicity. 22 Apr 2009
• Metformin-induced encephalopathy without lactic acidosis in a patient with contraindication for metformin. 30 Mar 2009
• [Neurological symptoms in patient with focal segmental glomerulosclerosis treated with cyclosporin A--case report] 30 Mar 2009
• A reversible cause of blindness that should not be forgotten: cyclosporine-induced posterior reversible encephalopathy syndrome. 30 Mar 2009
• Mesial temporal sclerosis associated with methotrexate-induced leukoencephalopathy. 30 Mar 2009
• Posterior reversible encephalopathy syndrome associated with methotrexate neurotoxicity: conventional magnetic resonance and diffusion-weighted imaging findings. 21 Mar 2009
• Methylene blue-associated serotonin syndrome: a 'green' encephalopathy after parathyroidectomy. 3 Mar 2009
• Structural and diffusional brain abnormality related to relatively low level alcohol consumption. 18 Feb 2009
• Ceftriaxone-induced acute reversible encephalopathy in a patient treated for a urinary tract infection. 30 Jan 2009
• Posterior reversible encephalopathy syndrome after combined general and spinal anesthesia with intrathecal morphine. 30 Jan 2009
• Simultaneous two-voxel localized (1)H-observed (13)C-edited spectroscopy for in vivo MRS on rat brain at 9.4T: Application to the investigation of excitotoxic lesions. 23 Jan 2009
• Molecular imaging of retinal gliosis in transgenic mice induced by kainic acid neurotoxicity. 15 Jan 2009
• Loss of ETHE1, a mitochondrial dioxygenase, causes fatal sulfide toxicity in ethylmalonic encephalopathy. 9 Jan 2009
• Neurotoxic lesions of the thalamic reuniens or mediodorsal nucleus in rats affect non-mnemonic aspects of watermaze learning. 7 Jan 2009
• [Cefepime-induced encephalopathy in patients with renal failure] 30 Dec 2008

See a longer list of these articles.

Technical information about 'Brain Diseases'

Definition: Pathologic conditions affecting the BRAIN, which is composed of the intracranial components of the CENTRAL NERVOUS SYSTEM. This includes (but is not limited to) the CEREBRAL CORTEX; intracranial white matter; BASAL GANGLIA; THALAMUS; HYPOTHALAMUS; BRAIN STEM; and CEREBELLUM.

Descriptor UI: D001927

Alternative terms: Brain Diseases; Brain Disease; Central Nervous System Disorders, Intracranial; Intracranial CNS Disorders; CNS Disorders, Intracranial; CNS Disorder, Intracranial; Intracranial CNS Disorder; Encephalon Diseases; Encephalon Disease; Intracranial Central Nervous System Disorders; Brain Disorders; Brain Disorder; Central Nervous System Intracranial Disorders; Pathology, Brain; Brain Pathology;

Allowable Qualifiers: blood; cerebrospinal fluid; chemically induced; classification; complications; congenital; diagnosis; diet therapy; drug therapy; economics; embryology; enzymology; ethnology; etiology; genetics; history; immunology; metabolism; microbiology; mortality; nursing; epidemiology; parasitology; pathology; physiopathology; prevention & control; psychology; radiography; radionuclide imaging; radiotherapy; rehabilitation; surgery; therapy; urine; veterinary; ultrasonography; virology;

Tree Number: C10.228.140;